Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-05-05

FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for Simvastatin from NorthStar Rx LLC, approving the continued marketing of this generic statin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

SUPPL AP for SIMVASTATIN (SIMVASTATIN)